Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Corteva, Inc.CTVA · Entity 3006 | Director · Chief Executive Officer | February 28, 2026 | March 02, 2026 |
| Ingredion IncINGR · Entity 3745 | Director | September 30, 2026 | October 02, 2026 |
| Vylor Inc.VYLR · Entity 183857 | Chief Executive Officer | October 01, 2026 | October 06, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Corteva, Inc.
Report date February 28, 2026 · Filed March 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 349,214.1357 |
Reported balance
After 2026-02-28 transaction · row 1
1 source rowRow 1 · 2026-02-28 · Tax withholding · Disposed 4,958 · Balance 349,214.1357 F1: Represents shares withheld by the Issuer to pay taxes due following the vesting of previously granted restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents shares withheld by the Issuer to pay taxes due following the vesting of previously granted restricted stock units.
Ingredion Inc
Report date September 30, 2026 · Filed October 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Phantom StockSEC Table II · derivative / convertible security | Direct | 771.7435 |
Reported balance
After 2026-09-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-30 · Grant · Acquired 266 · Balance 771.7435 F1: Represents the aggregate number of shares of phantom stock allocated to the reporting person based upon a deferral of a cash retainer under the Non-Qualified Deferred Compensation Plan as of the date hereof based on the closing price of a share of the issuer's Common Stock on September 30, 2026. Each phantom stock unit represents the right to receive one share of common stock. F2: Includes shares of phantom stock acquired through dividend reinvestment. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents the aggregate number of shares of phantom stock allocated to the reporting person based upon a deferral of a cash retainer under the Non-Qualified Deferred Compensation Plan as of the date hereof based on the closing price of a share of the issuer's Common Stock on September 30, 2026. Each phantom stock unit represents the right to receive one share of common stock.
F2: Includes shares of phantom stock acquired through dividend reinvestment.
Vylor Inc.
Report date October 01, 2026 · Filed October 06, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CommonSEC Table I · non-derivative | Direct | 834,808.9865 |
Reported balance
After 2026-10-01 transaction · row 1
1 source rowRow 1 · 2026-10-01 · Other · Acquired 834,808.9865 · Balance 834,808.9865 F1: On October 1, 2026, the Reporting Person received a dividend of one (1) share of Vylor Inc. ("Vylor") common stock for every one (1) share of Corteva Inc. ("Corteva") common stock held by the Reporting Person, and the Reporting Person's equity awards denominated in Corteva common stock were adjusted, in part, into equity awards denominated in Vylor common stock, in connection with the spin-off of Vylor from Corteva. This amount includes the Vylor common stock received in connection with the spin-off in an exempt transaction pursuant to Rule 16b-3, including restricted stock units and dividend equivalent units. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $45.00 · Expires 2032-02-18 | Direct | 145,694 |
Reported balance
After 2026-10-01 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-10-01 · Other · Acquired 145,694 · Balance 145,694 F2: Represents equity awards originally granted by Corteva that have been converted into Vylor equity awards in connection with the spin-off of Vylor from Corteva, as described in Vylor's Resigistration Statement on Form 10 filed with the SEC on September 21, 2026. These options are vested and exercisable. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $57.22 · Expires 2035-02-18 | Direct | 110,257 |
Reported balance
After 2026-10-01 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2026-10-01 · Other · Acquired 110,257 · Balance 110,257 F3: Represents equity awards originally granted by Corteva that have been converted into Vylor equity awards in connection with the spin-off of Vylor from Corteva, as described in Vylor's Resigistration Statement on Form 10 filed with the SEC on September 21, 2026. 36,751 options are vested and exercisable. The remainingoptions will vest in two equal installments on February 18, 2027 and February 18, 2028. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $48.25 · Expires 2034-02-20 | Direct | 131,778 |
Reported balance
After 2026-10-01 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2026-10-01 · Other · Acquired 131,778 · Balance 131,778 F4: Represents equity awards originally granted by Corteva that have been converted into Vylor equity awards in connection with the spin-off of Vylor from Corteva, as described in Vylor's Resigistration Statement on Form 10 filed with the SEC on September 21, 2026. The remainingoptions will vest on February 20, 2027. |
| Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $55.29 · Expires 2033-02-28 | Direct | 107,830 |
Reported balance
After 2026-10-01 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2026-10-01 · Other · Acquired 107,830 · Balance 107,830 F2: Represents equity awards originally granted by Corteva that have been converted into Vylor equity awards in connection with the spin-off of Vylor from Corteva, as described in Vylor's Resigistration Statement on Form 10 filed with the SEC on September 21, 2026. These options are vested and exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: On October 1, 2026, the Reporting Person received a dividend of one (1) share of Vylor Inc. ("Vylor") common stock for every one (1) share of Corteva Inc. ("Corteva") common stock held by the Reporting Person, and the Reporting Person's equity awards denominated in Corteva common stock were adjusted, in part, into equity awards denominated in Vylor common stock, in connection with the spin-off of Vylor from Corteva. This amount includes the Vylor common stock received in connection with the spin-off in an exempt transaction pursuant to Rule 16b-3, including restricted stock units and dividend equivalent units.
F2: Represents equity awards originally granted by Corteva that have been converted into Vylor equity awards in connection with the spin-off of Vylor from Corteva, as described in Vylor's Resigistration Statement on Form 10 filed with the SEC on September 21, 2026. These options are vested and exercisable.
F3: Represents equity awards originally granted by Corteva that have been converted into Vylor equity awards in connection with the spin-off of Vylor from Corteva, as described in Vylor's Resigistration Statement on Form 10 filed with the SEC on September 21, 2026. 36,751 options are vested and exercisable. The remainingoptions will vest in two equal installments on February 18, 2027 and February 18, 2028.
F4: Represents equity awards originally granted by Corteva that have been converted into Vylor equity awards in connection with the spin-off of Vylor from Corteva, as described in Vylor's Resigistration Statement on Form 10 filed with the SEC on September 21, 2026. The remainingoptions will vest on February 20, 2027.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 11, 2022 Filed Feb 15, 2022 22:04 UTC | Corteva, Inc. CTVA · Entity 3006 | PurchaseCommon Stock | 46,250 | $51.10 | $2,363,282.50 |
DisclosureSEC source: 0001209191-22-009822 · doc4.xml · nonDerivative · entry 1 Magro Charles V. · CIK 0001893081 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,250 F1 · price: The price reported represents the weighted average price. These shares were purchased in multiple transactions at prices ranging from $50.56 to $51.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.